We explored this versatile expression in the context of melanoma in a previously published scRNAseq melanoma dataset,26 which revealed that MITF is specifically expressed in tumor cells, whereas AXL expression is highest in CAFs and tumor-associated macrophages (TAMs) (Supplementary Figure S3A-E, available at https://doi.org/10.1016/j.iotech.2024.101009). The gene discussed is MITF; the disease is melanoma.